Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Alberta

$84,835.00

Growth hormone as an autocrine/paracrine factor in chick embryogenesis: an retinal model

FY 2012-13

Summary
This proposal is an extension of an ongoing program of research on the physiology of GH secretion and action. In postnatal development, GH is secreted from the pituitary gland (at the base of the brain) into the bloodstream, through which it gains access to every tissue in the body. These tissues express receptors that mediate the actions of pituitary GH on cellular growth and differentiation. However, while these 'endocrine' actions of pituitary GH are obligatory for postnatal development, embryonic or fetal growth is thought to be a 'growth-without-GH-syndrome', since it occurs prior to the development of the circulatory system and the differentiation of the pituitary gland. Embryonic or fetal growth is thus thought to be induced locally by tissue growth factors. Growth in the embryo may not, however, be 'paradoxical' since it may be mediated by local actions of GH produced in early embryonic tissues. The applicant has recently discovered that GH gene expression is not confined to the pituitary gland and occurs almost ubiquitously in tissues of the chick embryo. 'Autocrine' or 'paracrine' actions of GH (actions in GH-producing cells or neighboring cells, respectively) may therefore regulate embryonic growth. In the studies proposed, the applicant will increase or decrease GH status in the neural retina and retinal ganglion cells (RGCs) of early chick embryos and determine its effects on retinal function and retinal development. Specifically, the effects of retinal GH excess and deficiency on cell survival, proliferation, migration, neurite outgrowth, angiogenesis and synaptogenesis will be determined. The possibility that these actions may be direct or mediated via insulin-like-growth factor (IGF)-1, another tissue growth factor implicated in the 'endocrine' actions of pituitary GH, will also be assessed. The factors regulating retinal GH production or secretion will also be determined. These studies will provide a model for understanding the secretion and action of GH during embryonic or fetal growth, particularly in retinal and neural development.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
3617-2007
Name nom
Harvey, Stephen
Department département
Physiology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2007
Award amount
84835
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1011
Committee name en
Integrative Animal Biology
Committee name fr
Biologie Animale Intégrative
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5500
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal biology
Research subject fr
Biologie animale
Partie
5
Nb partie
5
Application title
Growth hormone as an autocrine/paracrine factor in chick embryogenesis: an retinal model
Keyword
NSERC
Application summary
This proposal is an extension of an ongoing program of research on the physiology of GH secretion and action. In postnatal development, GH is secreted from the pituitary gland (at the base of the brain) into the bloodstream, through which it gains access to every tissue in the body. These tissues express receptors that mediate the actions of pituitary GH on cellular growth and differentiation. However, while these 'endocrine' actions of pituitary GH are obligatory for postnatal development, embryonic or fetal growth is thought to be a 'growth-without-GH-syndrome', since it occurs prior to the development of the circulatory system and the differentiation of the pituitary gland. Embryonic or fetal growth is thus thought to be induced locally by tissue growth factors. Growth in the embryo may not, however, be 'paradoxical' since it may be mediated by local actions of GH produced in early embryonic tissues. The applicant has recently discovered that GH gene expression is not confined to the pituitary gland and occurs almost ubiquitously in tissues of the chick embryo. 'Autocrine' or 'paracrine' actions of GH (actions in GH-producing cells or neighboring cells, respectively) may therefore regulate embryonic growth. In the studies proposed, the applicant will increase or decrease GH status in the neural retina and retinal ganglion cells (RGCs) of early chick embryos and determine its effects on retinal function and retinal development. Specifically, the effects of retinal GH excess and deficiency on cell survival, proliferation, migration, neurite outgrowth, angiogenesis and synaptogenesis will be determined. The possibility that these actions may be direct or mediated via insulin-like-growth factor (IGF)-1, another tissue growth factor implicated in the 'endocrine' actions of pituitary GH, will also be assessed. The factors regulating retinal GH production or secretion will also be determined. These studies will provide a model for understanding the secretion and action of GH during embryonic or fetal growth, particularly in retinal and neural development.